These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 10967748)

  • 1. Free radicals as mediators of toxicity in Alzheimer's disease: a review and hypothesis.
    Tabet N; Mantle D; Orrell M
    Adverse Drug React Toxicol Rev; 2000 Jun; 19(2):127-52. PubMed ID: 10967748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease.
    Reddy PH
    J Neurochem; 2006 Jan; 96(1):1-13. PubMed ID: 16305625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
    Roy S; Rauk A
    Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into amyloid-beta-induced mitochondrial dysfunction in Alzheimer disease.
    Wang X; Su B; Perry G; Smith MA; Zhu X
    Free Radic Biol Med; 2007 Dec; 43(12):1569-73. PubMed ID: 18037122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial Abeta: a potential cause of metabolic dysfunction in Alzheimer's disease.
    Chen X; Yan SD
    IUBMB Life; 2006 Dec; 58(12):686-94. PubMed ID: 17424907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hallmarks of protein oxidative damage in neurodegenerative diseases: focus on Alzheimer's disease.
    Polidori MC; Griffiths HR; Mariani E; Mecocci P
    Amino Acids; 2007; 32(4):553-9. PubMed ID: 17273806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics, lifestyle and the roles of amyloid beta and oxidative stress in Alzheimer's disease.
    Veurink G; Fuller SJ; Atwood CS; Martins RN
    Ann Hum Biol; 2003; 30(6):639-67. PubMed ID: 14675907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid beta peptide levels.
    Pacheco-Quinto J; Rodriguez de Turco EB; DeRosa S; Howard A; Cruz-Sanchez F; Sambamurti K; Refolo L; Petanceska S; Pappolla MA
    Neurobiol Dis; 2006 Jun; 22(3):651-6. PubMed ID: 16516482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic role of mitochondrial [correction of mitochondral] amyloid-beta peptide.
    Chen JX; Yan SD
    Expert Rev Neurother; 2007 Nov; 7(11):1517-25. PubMed ID: 17997700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abeta40, either soluble or aggregated, is a remarkably potent antioxidant in cell-free oxidative systems.
    Baruch-Suchodolsky R; Fischer B
    Biochemistry; 2009 May; 48(20):4354-70. PubMed ID: 19320465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment.
    Mangialasche F; Polidori MC; Monastero R; Ercolani S; Camarda C; Cecchetti R; Mecocci P
    Ageing Res Rev; 2009 Oct; 8(4):285-305. PubMed ID: 19376275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free radical oxidative damage and Alzheimer's disease.
    Tuppo EE; Forman LJ
    J Am Osteopath Assoc; 2001 Dec; 101(12 Suppl Pt 1):S11-5. PubMed ID: 11794746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease.
    Swerdlow RH; Khan SM
    Med Hypotheses; 2004; 63(1):8-20. PubMed ID: 15193340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic treatments for Alzheimer's disease based on metal bioavailability.
    Crouch PJ; Barnham KJ; Bush AI; White AR
    Drug News Perspect; 2006 Oct; 19(8):469-74. PubMed ID: 17160147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of free radicals and metal ions in the pathogenesis of Alzheimer's disease.
    Atwood CS; Huang X; Moir RD; Tanzi RE; Bush AI
    Met Ions Biol Syst; 1999; 36():309-64. PubMed ID: 10093929
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanisms of neurotoxicity associated with amyloid beta deposition and the role of free radicals in the pathogenesis of Alzheimer's disease: a critical appraisal.
    Sayre LM; Zagorski MG; Surewicz WK; Krafft GA; Perry G
    Chem Res Toxicol; 1997 May; 10(5):518-26. PubMed ID: 9168248
    [No Abstract]   [Full Text] [Related]  

  • 18. Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease.
    Aliyev A; Chen SG; Seyidova D; Smith MA; Perry G; de la Torre J; Aliev G
    J Neurol Sci; 2005 Mar; 229-230():285-92. PubMed ID: 15760652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrillar and oligomeric beta-amyloid as distinct local biomarkers for Alzheimer's disease.
    Montalto MC; Farrar G; Hehir CT
    Ann N Y Acad Sci; 2007 Feb; 1097():239-58. PubMed ID: 17413026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease.
    Atamna H; Frey WH
    Mitochondrion; 2007 Sep; 7(5):297-310. PubMed ID: 17625988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.